Progressive Multiple Sclerosis
Neurology·MeSH: Multiple Sclerosis, Chronic Progressive
Prevalence
120.0 / 100K
Incidence
7.0 / 100K/yr
7 drugs in development·5 companies·5 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Progressive Multiple Sclerosis?
BioSniper tracks 7 drugs in development for Progressive Multiple Sclerosis across 5 companies.
How many clinical trials target Progressive Multiple Sclerosis?
There are 5 clinical trials targeting Progressive Multiple Sclerosis tracked by BioSniper.
What is the prevalence of Progressive Multiple Sclerosis?
The estimated prevalence of Progressive Multiple Sclerosis is approximately 120.0 per 100,000 population.
Deep-dive into Progressive Multiple Sclerosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis